Get started
Author

Laura Llorente

Observed names: L. Llorente, L.M. San-frutos Llorente, Laura Iglesias Llorente, Laura Iglesias-Llorente, Laura LLorente
ORCID: 0000-0003-3311-7240
Observed ORCID: 0000-0003-3311-7240
OpenAlex ID: A5028097465
Characteristics and predictors of death among 4035 consecutively hospitalized patients with COVID-19 in Spain
2020 · Juan Berenguer, Pablo Ryan, et al. · Clinical Microbiology and Infection · 401
PDF
Identification and validation of clinical phenotypes with prognostic implications in patients admitted to hospital with COVID-19: a multicentre cohort study
2021 · Belén Gutiérrez-Gutiérrez, María Dolores del Toro, et al. · The Lancet Infectious Diseases · 100
PDF
Pseudomonas aeruginosa antibiotic susceptibility profiles, genomic epidemiology and resistance mechanisms: a nation-wide five-year time lapse analysis
2023 · Miquel Àngel Sastre-Femenia, Almudena Fernández-Muñoz, et al. · The Lancet Regional Health - Europe · 97
Frequency, Clinical Characteristics and Outcome of Adults With Acute Lymphoblastic Leukemia and COVID 19 Infection in the First vs. Second Pandemic Wave in Spain
2021 · Josep-Maria Ribera, Mireia Morgades, et al. · Clinical Lymphoma Myeloma & Leukemia · 21
PDF
Real-World Outcomes of Belantamab Mafodotin for Relapsed/Refractory Multiple Myeloma (RRMM): Preliminary Results of a Spanish Expanded Access Program (EAP)
2022 · Adrián Alegre, Gonzalo Benzo, et al. · Oncology and Therapy · 17
PDF
Outcomes and prognostic factors of adults with refractory or relapsed T‐cell acute lymphoblastic leukemia included in measurable residual disease‐oriented trials
2021 · Josep‐Maria Ribera, Mireia Morgades, et al. · Hematological Oncology · 13
Feasibility and outcomes after dose reduction of immunochemotherapy in young adults with Burkitt lymphoma and leukemia: results of the BURKIMAB14 trial
2023 · Josep-Maria Ribera, Mireia Morgades, et al. · Haematologica · 7
PDF
Significación pronóstica del volumen metabólico tumoral y de la glucólisis tumoral total en pacientes con cáncer cervical avanzado
2018 · L. Calles-Sastre, J. Mucientes-Rasilla, et al. · Revista Española de Medicina Nuclear e Imagen Molecular · 7
Myocardial uptake of 99mTc-DPD in patients with AL amyloidosis
2017 · Carlos de Miguel, Laura Llorente, et al. · Amyloid · 6
Compassionate Use of Belantamab Mafodotin for Treatment of Patients with Relapsed/Refractory Multiple Myeloma Heavily Treated. Spanish Experience
2021 · Adrian Alegre, Gonzalo Benzo Callejo, et al. · Blood · 4
Case Report: Ambergris coprolite and septicemia in a male sperm whale stranded in La Palma (Canary Islands)
2024 · Antonio Fernández, Cristian Suárez-Santana, et al. · Frontiers in Veterinary Science · 2
Complement Genotype and Multiparametric Laboratory Analysis to Predict Response to Eculizumab and to Adjust Treatment in Patients with Paroxysmal Nocturnal Hemoglobinuria
2015 · Marta Subías-Hidalgo, Alicia Lopez, et al. · Blood · 2
Frequency, Clinical Characteristics and Outcome of Adult Patients with Acute Lymphoblastic Leukemia (ALL) and COVID-19 in Spain: Results of a Survey from Pethema and Geth Groups
2020 · Josep-Maria Ribera, Mireia Morgades, et al. · Blood · 1
Limitations of PCR-based detection of Neisseria meningitidis: The potential influence of non-encapsulated strains on diagnostic failure
2026 · Miguel Fernández-Huerta, Eduardo Lagarejos, et al. · Diagnostic Microbiology and Infectious Disease
POSTER: ABCL-296 Polatuzumab-R-CHP in Previously Untreated Diffuse Large B-Cell Lymphoma: A Retrospective Study
2025 · Alejandro Bobes, Laura Llorente, et al. · Clinical Lymphoma Myeloma & Leukemia
ABCL-296: Polatuzumab-R-CHP in Previously Untreated Diffuse Large B-Cell Lymphoma: A Retrospective Study
2025 · Alejandro Bobes, Laura Llorente, et al. · Clinical Lymphoma Myeloma & Leukemia
ABCL-427 Polatuzumab-R-CHP in Previously Untreated Diffuse Large B-Cell Lymphoma: A Retrospective Study
2024 · Alejandro Bobes, Laura Llorente, et al. · Clinical Lymphoma Myeloma & Leukemia
Polatuzumab-R-CHP in Previously Untreated Diffuse Large B-Cell Lymphoma: A Retrospective Study
2024 · Alejandro Bobes, Laura Llorente, et al. · Clinical Lymphoma Myeloma & Leukemia
P1147: Feasibility and Outcome After Dose Reduction of Immunochemotherapy in Young Adults With Burkitt Lymphoma and Leukemia. Results of the Burkimab14 Trial
2023 · Josep Maria Ribera, Mireia Morgades, et al. · HemaSphere
Author response for "Outcomes and prognostic factors of adults with refractory or relapsed T‐cell acute lymphoblastic leukemia included in measurable residual disease‐oriented trials"
2021 · Josep‐Maria Ribera, Mireia Morgades, et al. · Publons reviews and discussion
Analysis of the Different Surveillance Strategies for Patients with Hodgkin Lymphoma in Clinical Remission after First-Line Treatment. a Study of the Geltamo Group (Spanish lymphoma and autologous transplant group)
2019 · Mariana Bastos-Oreiro, Nieves Lopez, et al. · Blood
Increased Expression Of PD-1 Checkpoint Molecule on Bone Marrow T-Cells from Patients With Multiple Myeloma: Potential Impact on Clinical Outcome?
2019 · Pablo Perez-Montero, Angel Paniagua, et al. · Clinical Lymphoma Myeloma & Leukemia
Pb2107 Upregulation of Pd-1 Checkpoint Receptor Molecule on Bone Marrow T-cells From Patients With Multiple Myeloma, and Its Potential Impact on Clinical Outcome
2019 · P. Perez-Montero, A. Paniagua, et al. · HemaSphere
Works count: 24
Citation count: 695
H-index: 7
I10-index: 7
Year
Topic
Type